Panoptes Pharma GES.M.B.H - Ownership and Business Overview

Life ScienceCompany

Panoptes Pharma GES.M.B.H Ownership

Who owns Panoptes Pharma GES.M.B.H?

Panoptes Pharma GES.M.B.H is owned by Kiora Pharmaceuticals. It was acquired on December 21, 2020.

Panoptes Pharma GES.M.B.H Business Overview

Where is Panoptes Pharma GES.M.B.H headquartered?

Panoptes Pharma GES.M.B.H is headquartered in Wien, Austria.

What sector is Panoptes Pharma GES.M.B.H in?

Panoptes Pharma GES.M.B.H is a life science company.

When was Panoptes Pharma GES.M.B.H founded?

Panoptes Pharma GES.M.B.H was founded in 2013.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 282 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 259 by strategics.

Panoptes Pharma GES.M.B.H

Reisnerstrabe 34/1,
Wien, 1030
Austria,
+43 664 8557369‬
www.panoptes-pharma.com

Panoptes Pharma GES.M.B.H is a clinical stage biotech company focused on developing a novel proprietary small molecule for the treatment of severe eye diseases with a high unmet medical need. Panoptes Pharma was founded in 2013 and is based in Wien, Austria.


 Subscribe to unlock this and 201,688
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Panoptes Pharma GES.M.B.H

Life Science Companies , Austria Companies